Medefil Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEDEFIL INC, and what generic and branded alternatives to MEDEFIL INC drugs are available?
MEDEFIL INC has four approved drugs.
Summary for Medefil Inc
US Patents: | 0 |
Tradenames: | 4 |
Ingredients: | 4 |
NDAs: | 4 |
Drug Master File Entries: | 1 |
Drugs and US Patents for Medefil Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medefil Inc | SODIUM CHLORIDE 0.9% | sodium chloride | INJECTABLE;INJECTION | 202832-003 | Jan 6, 2012 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Medefil Inc | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 214970-001 | Nov 4, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Medefil Inc | SODIUM CHLORIDE 0.9% | sodium chloride | INJECTABLE;INJECTION | 202832-004 | Jan 6, 2012 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Medefil Inc | CALCIUM CHLORIDE 10% | calcium chloride | INJECTABLE;INJECTION | 211553-001 | May 1, 2019 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.